NCT01376024 Study on Basal Joint Arthritis Prospective
| NCT ID | NCT01376024 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Osteoarthrosis of the Carpometacarpal Joint of the Thumb |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2007-03-02 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2007-03-02 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The data in this prospective registry will be used 1) to define which surgical and nonoperative techniques are most effective at providing pain relief, restoring function, are cost effective, and patients are satisfied with their outcomes; and 2) to design focused clinical questions regarding the optimal treatment of basal joint arthritis of the thumb in future randomized controlled trials. There are no interventions or changes in patient care associated with this study.
Eligibility Criteria
Inclusion Criteria: * Patients who have symptomatic basal joint arthritis. * Patients who are capable of providing informed consent. Exclusion Criteria: * Patients younger than 18 years old at the time of enrollment. * Patients with neuromuscular disease affecting the operated hand, not caused by the CMC operation. * Patients with known inflammatory arthritic conditions, such as rheumatoid or psoriatic arthritis. * Patients with a history of or current infection of the basal joint of the affected hand. * Patients who are demented or are unable to provide informed consent. * Patients unable to comply with study guidelines. * Patients who have metacarpophalangeal joint hyperextension are NOT excluded. These patients will be followed and if they receive a capsulodesis or other procedure at the MCPJ at the same time as their basal joint arthroplasty this will be noted in their data records.
Contact & Investigator
Melvin P Rosenwasser, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT01376024 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthrosis of the Carpometacarpal Joint of the Thumb. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01376024 currently recruiting?
Yes, NCT01376024 is actively recruiting participants. Contact the research team at mpr2@cumc.columbia.edu for enrollment information.
Where is the NCT01376024 trial being conducted?
This trial is being conducted at Rochester, United States, New York, United States, Nashville, United States.
Who is sponsoring the NCT01376024 clinical trial?
NCT01376024 is sponsored by Columbia University. The principal investigator is Melvin P Rosenwasser, MD at Columbia University. The trial plans to enroll 800 participants.